Cargando…

Preclinical Alzheimer's disease and longitudinal driving decline

INTRODUCTION: Links between preclinical Alzheimer's disease (AD) and driving difficulty onset would support the use of driving performance as an outcome in primary and secondary prevention trials among older adults (OAs). We examined whether AD biomarkers predicted the onset of driving difficul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roe, Catherine M., Babulal, Ganesh M., Head, Denise M., Stout, Sarah H., Vernon, Elizabeth K., Ghoshal, Nupur, Garland, Brad, Barco, Peggy P., Williams, Monique M., Johnson, Ann, Fierberg, Rebecca, Fague, M. Scot, Xiong, Chengjie, Mormino, Elizabeth, Grant, Elizabeth A., Holtzman, David M., Benzinger, Tammie L.S., Fagan, Anne M., Ott, Brian R., Carr, David B., Morris, John C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Featured Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396459/ https://www.ncbi.nlm.nih.gov/pubmed/28435853 http://dx.doi.org/10.1016/j.trci.2016.11.006

Ejemplares similares

Using the A/T/N Framework to Examine Driving in Preclinical Alzheimer’s Disease
por: Roe, Catherine M., et al.
Publicado: (2018)

Development and interval testing of a naturalistic driving methodology to evaluate driving behavior in clinical research
por: Babulal, Ganesh M., et al.
Publicado: (2016)

Association of Functional Impairments and Co-Morbid Conditions with Driving Performance among Cognitively Normal Older Adults
por: Carr, David B., et al.
Publicado: (2016)

Falls: a marker of preclinical Alzheimer disease: a cohort study protocol
por: Bollinger, Rebecca M, et al.
Publicado: (2021)

Lack of association between acute stroke, post-stroke dementia, race, and β-amyloid status
por: Koenig, Lauren N., et al.
Publicado: (2021)

Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer’s disease
por: Sutphen, Courtney L., et al.
Publicado: (2018)

Creating a driving profile for older adults using GPS devices and naturalistic driving methodology
por: Babulal, Ganesh M., et al.
Publicado: (2016)

Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2018)

The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia
por: Gordon, Brian A., et al.
Publicado: (2015)

A Systematic Review Examining Associations between Cardiovascular Conditions and Driving Outcomes among Older Drivers
por: Babulal, Ganesh M., et al.
Publicado: (2020)

Driving Outcomes among Older Adults: A Systematic Review on Racial and Ethnic Differences over 20 Years
por: Babulal, Ganesh M., et al.
Publicado: (2018)

African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic Variants
por: Schindler, Suzanne E., et al.
Publicado: (2021)

Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage
por: Meeker, Karin L., et al.
Publicado: (2022)

The Road to Recovery: A Pilot Study of Driving Behaviors Following Antibody-Mediated Encephalitis
por: Day, Gregory S., et al.
Publicado: (2020)

Comparing Tau PET Visual Interpretation with Tau PET Quantification, Cerebrospinal Fluid Biomarkers, and Longitudinal Clinical Assessment
por: Chen, Charles D., et al.
Publicado: (2023)

Translocator protein in late stage Alzheimer’s disease and Dementia with Lewy bodies brains
por: Xu, Jinbin, et al.
Publicado: (2019)

Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer’s disease in a memory clinic cohort
por: Kester, Maartje I., et al.
Publicado: (2015)

GPS driving: a digital biomarker for preclinical Alzheimer disease
por: Bayat, Sayeh, et al.
Publicado: (2021)

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease
por: Brier, Matthew R., et al.
Publicado: (2016)

Select Atrophied Regions in Alzheimer disease (SARA): An improved volumetric model for identifying Alzheimer disease dementia
por: Koenig, Lauren N., et al.
Publicado: (2020)

Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2019)

Associations Between Plasma, Imaging, and Cerebrospinal Fluid Biomarkers with Driving Behavior and Cognitive Tests: Implications for Biomarker Usefulness
por: Roe, Catherine M., et al.
Publicado: (2023)

The Importance of Advancing Research on Aging and Driving
por: Murphy, Samantha A., et al.
Publicado: (2021)

Data-driven models of dominantly-inherited Alzheimer’s disease progression
por: Oxtoby, Neil P, et al.
Publicado: (2018)

Quantitative Label-Free Proteomics for Discovery of Biomarkers in Cerebrospinal Fluid: Assessment of Technical and Inter-Individual Variation
por: Perrin, Richard J., et al.
Publicado: (2013)

CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease
por: Strain, Jeremy F., et al.
Publicado: (2022)

Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease
por: Yan, Shaozhen, et al.
Publicado: (2020)

Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease
por: Wang, Qing, et al.
Publicado: (2019)

Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies
por: Su, Yi, et al.
Publicado: (2018)

Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease
por: Llibre-Guerra, Jorge J., et al.
Publicado: (2019)

Relationships between big‐five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2020)

Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity
por: Rahmani, Farzaneh, et al.
Publicado: (2022)

Evaluation of Naturalistic Driving Behavior Using In-Vehicle Monitoring Technology in Preclinical and Early Alzheimer’s Disease
por: Davis, Jennifer D., et al.
Publicado: (2020)

The Spatial Patterns and Determinants of Cerebrospinal Fluid Circulation in the Human Brain
por: Nazeri, Arash, et al.
Publicado: (2023)

Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light
por: Schindler, Suzanne E., et al.
Publicado: (2022)

Uncertainties in the PET defined A‐/T(Neocortical)+ subtype
por: Mormino, Elizabeth C., et al.
Publicado: (2022)

Introduction to special edition, “State of the Field: Advances in Neuroimaging from the 2016 Alzheimer's Imaging Consortium”
por: Mormino, Elizabeth C., et al.
Publicado: (2016)

Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
por: Fagan, Anne M, et al.
Publicado: (2009)

Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
por: Craig-Schapiro, Rebecca, et al.
Publicado: (2011)

Planning for a Nondriving Future: Behaviors and Beliefs among Middle-Aged and Older Drivers
por: Harmon, Annie C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0ikhmhd0mqpk6fa6agdu1jfjlf